Stability of sulfasalazine oral suspension

Canadian Journal of Hospital Pharmacy

Volumn 59, Issue 4, 2006, Pages 194-200

  Linger Walsh, Karen ^a   Walker, Scott E ^b,c   Law, Shirley ^b   Abesamis, Marissa ^a   Sales, Pacita ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Drug stability; Sulfasalazine; Suspension

Indexed keywords

GLASS; ORA PLUS; ORA SWEET; POLYETHYLENE TEREPHTHALATE; POLYVINYLCHLORIDE; SALAZOSULFAPYRIDINE; UNCLASSIFIED DRUG;

ARTICLE; CANADA; CONTAINER; CONTROLLED STUDY; DEGRADATION KINETICS; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG QUALITY; DRUG STABILITY; DRUG STORAGE; PH; REVERSED PHASE LIQUID CHROMATOGRAPHY; STORAGE TEMPERATURE; SUSPENSION; VALIDATION PROCESS;

EID: 34250687926     PISSN: 00084123     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Salazopyrin En-Tabs. Pharmacia. In: Repchinsky C, editor. Compendium of pharmaceuticals and specialities. Ottawa (ON) Canadian Pharmacists Association; 2003. p. 1533-5.
2. [Allen LJ]. Sulfasalazine 250-mg/5mL oral liquid. Int J Pharm Compound 2003;7:474.
3. Teshima D, Hino B, Itoh Y, Oishi R. Simple and simultaneous determination of sulphapyridine and acetylsulphapyridine in human serum by column-switching high-performance liquid chromatography. J Clin Pharm Ther 2002;27:403-8.
4. Bugge CJ, Gautam SR, Parke LE, Mason JT, Garcia DB. Simultaneous determination of sulfasalazine and its metabolites sulfapyridine and N-acetylsulfapyridine in human serum by ion-pair high-performance liquid chromatography using a polymer-based column. J Pharm Sci 1990;79:1095-8.
5. Hansen SH. Simple and rapid method for the simultaneous determination of the eight main metabolites and conjugates of sulphasalazine in human plasma, urine and faeces using dynamically modified silica. J Chromatogr A 1989;491(1):175-85.
6. Chungi VS, Rekhi GS, Shargel L. A simple and rapid liquid chromatographic method for the determination of major metabolites of sulfasalazine in biological fluids. J Pharm Sci 1989;78:235-8.
7. Staniforth DH, Coates P, Clarke JG. An HPLC assay for sulphapyridine in plasma and its use to assess small bowel transit time after the administration of sulphasalazine. Int J Clin Pharmacol Ther Toxicol 1987;25:406-9.
8. Lee EJ, Ang SB. Simple and sensitive high-performance liquid chromatographic assay for 5-aminosalicylic acid and acetyl-5-aminosalicylic acid in serum. J Chromatogr A 1987;415:300-4.
9. van Hogezand RA, van Balen HC, van Schaik A, Tangerman A, van Hees PA, Zwanenburg B, et al. Determination of sodium azodisalicylate, salazosulphapyridine and their metabolites in serum, urine and faeces by high-performance liquid chromatography. J Chromatogr A 1984;305:470-6.
10. Shaw PN, Sivner AL, Aarons L, Houston JB. A rapid method for the simultaneous determination of the major metabolites of sulphasalazine in plasma. J Chromatogr A 1983;274:393-7.
11. Fischer C, Maier K, Klotz U. Simplified high-performance liquid chromatographic method for 5-aminosalicylic acid in plasma and urine. J Chromatogr A 1981;225:498-503.
12. Fischer C, Klotz U. High-performance liquid chromatographic determination of aminosalicylate, sulfapyridine and their metabolites: its application for pharmacokinetic studies with salicylazosulfapyridine in man. J Chromatogr A 1979;162:237-43.
13. Owerbach J, Johnson NF, Bates TR, Pieniaszek HJ Jr, Jusko WJ. High-performance liquid chromatographic assay of sulfapyridine and acetylsulfapyridine in biological fluids. J Pharm Sci 1978;67:1250-3.
14. Lanbeck K, Lindstrom B. Determination of salicylazosulphapyridine and sulphapyridine in plasma using high-performance liquid chromatography. J Chromatogr A 1978;154:321-4.
15. Fischer C, Klotz U. Determination of sulfapyridine and its major metabolites in plasma by high pressure liquid chromatography. J Chromatogr A 1978;146:157-62.
16. Egli KL. Liquid chromatographic determination of sulfasalazine in tablets and bulk powder. J Assoc Off Anal Chem 1985;68:803-6.
17. Bighley LD, McDonnell JP. High-speed liquid chromatographic analysis of sulfasalazine (salicylazosulfapyridine). J Pharm Sci 1975;64:1549-53.
18. Trissel LA. Avoiding common flaws in stability and compatibility studies of injectable drugs. Am J Hosp Pharm 1983;40:1159-60.
19. Trissel LA, Flora KP. Stability studies: five years later. Am J Hosp Pharm 1988;45:1569-71.
20. Policy for publication of chemical stability study manuscripts. Can J Hosp Pharm 1990;43:3-4.
21. Shah VP, Midha KK, Dighe S, McGilveray IJ, Skelly JP, Yacobi A, et al. Analytical methods validation: Bioavailability, bioequivalence and pharmacokinetic studies. J Pharm Sci 1992;81:309-12.
22. Frieman JA, Chalmers TC, Smith H Jr, Kuebler RR. The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 "negative" trials. N Engl J Med 1978;299:690-4.
23. Stolley PD, Strom BL. Sample size calculations for clinical pharmacology studies. Clin Pharmacol Ther 1986;39:489-90.